Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Apr 22, 2017 11:25pm
249 Views
Post# 26153804

RE:Partnerships: with a strategic venture or big pharma partner

RE:Partnerships: with a strategic venture or big pharma partnerAnd I'd like to put a caveat on my "ACTUAL PHARMA DEAL" comment...  Actual pharma deals need to be with ACTUAL PHARMACEUTICAL COMPANIES to count, and I am only going to count Pharma companies that I don't have to Google to see WTF they are...  Also Pharma companies in countries we are at WAR with, or close to being at war with, DO NOT COUNT.  Backwards deals that look nice but in the fine print we don't actually get anything, also don't count.  Time to put a REAL DEAL on the table - no more BS.  REAL PHARMA companies actually go out all the time and drop hundreds of millions or even BILLIONS on deals with tiny companies to buy new drugs.  If 4050 or PG are any good, then these companies - REAL ONES that we have all heard of - will want to pay up for these opportunities.  If these BIG companies don't / won't pay up, it will be obvious VERY SOON to all of us, and I think the writing will be on the wall for 4050 and PG.  If these drugs are all that, the CASH will be there from the big companies.  If it isn't, time to move on quick.  
Bullboard Posts